ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Ultragenyx Pharmaceutical, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -20.90% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -48.87%, its profits have fallen by -1.4%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -48.87% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ultragenyx Pharmaceutical, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Ultragenyx Pharmaceutical, Inc.
-47.84%
-0.73
72.21%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.94%
EBIT Growth (5y)
-20.90%
EBIT to Interest (avg)
-10.77
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.49
Sales to Capital Employed (avg)
0.50
Tax Ratio
0.45%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-26.36
EV to EBIT
-4.93
EV to EBITDA
-5.28
EV to Capital Employed
5.81
EV to Sales
3.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-117.74%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
Higher at USD -310.09 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.96 times
DEBT-EQUITY RATIO
(HY)
Lowest at -698.75 %
NET SALES(Q)
Highest at USD 207 MM
OPERATING PROFIT MARGIN(Q)
Highest at -50.83 %
-6What is not working for the Company
ROCE(HY)
Lowest at -656.54%
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.76 times
INTEREST(Q)
Highest at USD 19 MM
Here's what is working for Ultragenyx Pharmaceutical, Inc.
Net Profit
Higher at USD -310.09 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 2.96 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
Highest at USD 207 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 207 MM has Grown at 31.3%
over average net sales of the previous four periods of USD 157.65 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit Margin
Highest at -50.83 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Debt-Equity Ratio
Lowest at -698.75 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Ultragenyx Pharmaceutical, Inc.
Interest
At USD 19 MM has Grown at 34.29%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 19 MM
in the last five periods and Increased by 34.29% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debtors Turnover Ratio
Lowest at 4.76 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
